Mondrian Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-276,430	Closed	-$14.8M	–	139
2016 Q1	$14.8M	Sell	276,430 -1,164,198	-81%	-$68.3M	0.33%	58
2015 Q4	$94.6M	Sell	1,440,628 -3,944,092	-73%	-$244M	2.08%	13
2015 Q3	$304M	Sell	5,384,720 -5,097,549	-49%	-$331M	6.44%	2
2015 Q2	$620M	Buy	10,482,269 +26,709	+0.3%	+$1.65M	10.5%	1
2015 Q1	$651M	Sell	10,455,560 -573,926	-5%	-$33.4M	10.64%	1
2014 Q4	$634M	Sell	11,029,486 -4,895,292	-31%	-$273M	10.22%	1
2014 Q3	$856M	Sell	15,924,778 -1,391,100	-8%	-$73.7M	11.89%	1
2014 Q2	$908M	Sell	17,315,878 -314,300	-2%	-$16.1M	12.74%	1
2014 Q1	$932M	Sell	17,630,178 -4,749,322	-21%	-$220M	13.67%	1
2013 Q4	$897M	Buy	22,379,500 +970,339	+5%	+$38.2M	12.56%	1
2013 Q3	$809M	Buy	21,409,161 +130,666	+0.6%	+$5.1M	11.92%	1
2013 Q2	$834M	Buy	+21,278,495	New	+$829M	12.7%	1